幕上大脑半球脑膜瘤术前血管内栓塞后肿瘤体积、弥散与灌注的纵向影像研究
这项前瞻性、单中心、单臂研究纳入14例有症状的幕上脑膜瘤患者,采用校准微球行术前栓塞,评估栓塞后6小时与48小时的MRI弥散、灌注、磁敏感及T1增强序列变化,并与血管造影和临床数据相关。结果显示表观弥散系数、相对脑血容量与相对脑血流量比值及存活强化肿瘤体积均在6小时和48小时显著下降,血管造影去血管化率与栓塞后肿瘤体积相关良好。作者认为校准微球术前栓塞安全,并在48小时内有效诱导显著且持续的组织改变。
要点
- 栓塞后6小时与48小时表观弥散系数均较基线显著下降。
- 肿瘤/白质相对脑血容量与相对脑血流量比值在6小时和48小时均显著下降。
- 存活强化肿瘤体积在6小时和48小时均较基线显著缩小,作者认为该栓塞方式安全。
核心结论
- 采用校准微球行术前脑膜瘤栓塞是安全的,并在48小时内有效诱导显著且持续的组织改变。
研究设计与样本
- 前瞻性、单中心、单臂研究,共纳入14例有症状的幕上脑膜瘤患者,评估栓塞后6小时和48小时的MRI弥散加权成像、动态磁敏感灌注加权成像、磁敏感加权成像及磁化准备快速采集梯度回波序列T1增强序列变化,并与血管造影和临床数据相关。
主要发现
- 栓塞后基线表观弥散系数(901 ± 166 mm2/s)在6小时内显著下降(696 ± 115 mm2/s,P = 0.0008),48小时内亦显著下降(752 ± 134 mm2/s;P = 0.0147)。
- 基线相对脑血容量肿瘤/白质比值(3.67 ± 1.83)与相对脑血流量肿瘤/白质比值(2.89 ± 1.57)在栓塞后6小时内显著下降(相对脑血容量肿瘤/白质比值为1.45 ± 0.9,P = 0.0007;相对脑血流量为1.16 ± 0.68,P = 0.0029),48小时亦显著下降(相对脑血容量为1.50 ± 1.07,P = 0.0009;相对脑血流量肿瘤/白质比值为1.19 ± 0.8,P = 0.003)。
- 存活强化基线平均肿瘤体积(54.3 ± 34.9 mm3)在栓塞后6小时内持续且显著缩小(26.6 ± 20.8 mm3;P = 0.02),48小时内亦显著缩小(29.7 ± 22.5 mm3;P = 0.035)。
- 血管造影去血管化率与栓塞后6小时肿瘤体积相关良好(r = 0.7;P = 0.03),与48小时肿瘤体积亦相关良好(r = 0.78;P = 0.041)。
- 患者平均年龄63 ± 12.7岁,男女比例相等;12例脑膜瘤为世界卫生组织I级和II级肿瘤。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To describe longitudinal image changes in supratentorial hemispheric meningiomas based on magnetic resonance imaging after preoperative embolization using calibrated microspheres. METHODS: A total of 14 patients with symptomatic supratentorial meningiomas were included in a prospective, mono-centric, mono-arm study. Magnetic resonance imaging changes on diffusion-weighted imaging, dynamic contrast susceptibility-perfusion-weighted imaging, susceptibility-weighted imaging, and magnetization-prepared rapid acquisition gradient-echo sequence T1-weighted postcontrast sequences 6 and 48 hours after embolization were evaluated and correlated with angiographic and clinical data. RESULTS: The mean age of the patients was 63 ± 12.7 years with an equal female/male ratio. Twelve meningiomas were World Health Organization grade I and II tumors. After embolization, baseline apparent diffusion coefficient (901 ± 166 mm2/s) decreased significantly within 6 hours (696 ± 115 mm2/s, P = 0.0008) as well within 48 hours (752 ± 134 mm2/s; P = 0.0147). Baseline mean ratio of relative cerebral blood volume (rCBV)tumor/rCBVwhite matter (3.67 ± 1.83) and relative cerebral blood flow (rCBF)tumor/rCBFwhite matter (2.89 ± 1.57) significantly decreased after embolization within 6 hours (rCBVtumor/rCBVwhite matter of 1.45 ± 0.9; P = 0.0007, rCBF of 1.16 ± 0.68; P = 0.0029) and 48 hours (rCBV of 1.50 ± 1.07; P = 0.0009, rCBFtumor/rCBFwhite matter of 1.19 ± 0.8; P = 0.003). The viable enhanced baseline mean tumor volume (54.3 ± 34.9 mm3) was sustainably and significantly diminished within 6 hours (26.6 ± 20.8 mm3; P = 0.02) and 48 hours (29.7 ± 22.5 mm3; P = 0.035) after embolization. There was a good correlation between angiographic devascularization rate and the embolized tumor volume at 6 hours (r = 0.7; P = 0.03) and 48 hours (r = 0.78; P = 0.041). CONCLUSIONS: Preoperative meningioma embolization with calibrated microspheres is safe and effectively induces a significant and sustainable tissue transformation over 48 hours.
引用
- Gruber P, Schwyzer L, Klinger E, et al. Longitudinal Imaging of Tumor Volume, Diffusivity, and Perfusion After Preoperative Endovascular Embolization in Supratentorial Hemispheric Meningiomas. World Neurosurg. 2018. PMID: 30144590. doi:10.1016/j.wneu.2018.08.078
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。